Citation: Kiyotani K, Mushiroda T, Imamura CK, et al. Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients. J Clin Oncol. 2010;28:1287-1293.
Medscape Oncology © 2010
WebMD, LLC
Cite this: Kathy D. Miller. CYP2D6 Testing: Not Ready for Prime Time - Medscape - Apr 27, 2010.
Comments